Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2010Seminars in Thrombosis and Hemostasis

This document is a journal masthead and contains no clinical study data.

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Key result

This document is a journal masthead and contains no clinical study data.

Authors

BBBoris BigalkeBKBjörn KrämerPSPeter Seizer

Discussion

Loading...

Member takes

Overview

No clinical data in this masthead leaves open GPVI targeting for antithrombotic therapy and plaque imaging; prospective trials needed.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bigalke et al. (2010) studied this question. This document is a journal masthead and contains no clinical study data.

synapsesocial.com/papers/6a7da92eda6d5413e2cb519dhttps://doi.org/10.1055/s-0030-1251505
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Blocking platelet glycoprotein VI (GPVI) as a promising antithrombotic treatment2025 · 6 citations
  2. 2Glycoprotein VI interplay with fibrin(ogen) in thrombosis2023 · 32 citations
  3. 3Platelet and Soluble Glycoprotein VI - Novel Applications in Diagnosis and Therapy2011 · 15 citations
  4. 4Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation2015 · 271 citations
  5. 5Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo2003 · 197 citations